Insulet | Текущие Обязательства



Current Liabilities Изменить Дата
Abbott USD 14.16B 745M 2024-12
Align Technology USD 2.04B 25.59M 2024-12
AtriCure USD 73.42M 1.01M 2024-12
Avanos Medical USD 165.9M 47M 2024-12
Baxter International USD 6.51B 311M 2024-12
Becton, Dickinson and Co. USD 7.66B 1.29B 2024-12
Boston Scientific USD 6.4B 489M 2024-12
Cardinal Health USD 35.22B 545M 2024-12
Cooper Companies USD 999.6M 23.2M 2025-01
Dexcom USD 2.93B 1.2B 2024-12
Edwards Lifesciences USD 1.51B 438.9M 2024-12
Eli Lilly USD 28.38B 3.7B 2024-12
Globus Medical USD 855.91M 37.85M 2024-12
ICU Medical USD 556.18M 6.62M 2024-12
Insulet USD 528.4M 22.2M 2024-12
Integra LifeSciences USD 922.13M 9.56M 2024-12
J&J USD 50.32B 1.44B 2024-12
Masimo USD 617.7M 19.9M 2024-12
Medtronic USD 11.84B 355M 2025-01
Merit Medical Systems USD 216.4M 15.32M 2024-12
Roche Holding CHF 27.02B 424M 2024-12
Solventum Corp 2.7B 201M 2024-12
Stryker USD 7.62B 53M 2024-12
Tandem Diabetes Care USD 247.05M 12.23M 2024-12
Teleflex USD 649.36M 30.61M 2024-12
West Pharmaceutical Services USD 550.4M 33.9M 2024-12
Zimmer Biomet Holdings USD 2.45B 1.12B 2024-12



Insulet Текущие Обязательства - Текущие значения, предыдущие значения, прогнозы, графики и экономический календарь - Mar 2025.